Volitionrx (VNRX) Shareholder's Equity (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn | -35.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35.59 Mn |
| Sep 30, 2025 | -35.95 Mn |
| Jun 30, 2025 | -33.10 Mn |
| Mar 31, 2025 | -29.03 Mn |
| Dec 31, 2024 | -24.91 Mn |
| Sep 30, 2024 | -22.64 Mn |
| Jun 30, 2024 | -22.90 Mn |
| Mar 31, 2024 | -16.62 Mn |
| Dec 31, 2023 | -8.71 Mn |
| Sep 30, 2023 | -2.85 Mn |
| Jun 30, 2023 | 5.12 Mn |
| Mar 31, 2023 | -2.98 Mn |
| Dec 31, 2022 | -3.13 Mn |
| Sep 30, 2022 | 2.84 Mn |
| Jun 30, 2022 | 4.08 Mn |
| Mar 31, 2022 | 10.81 Mn |
| Dec 31, 2021 | 17.72 Mn |
| Sep 30, 2021 | 21.18 Mn |
| Jun 30, 2021 | 26.63 Mn |
| Mar 31, 2021 | 31.16 Mn |
| Dec 31, 2020 | 16.29 Mn |
| Sep 30, 2020 | 18.96 Mn |
| Jun 30, 2020 | 18.66 Mn |
| Mar 31, 2020 | 9.19 Mn |
| Dec 31, 2019 | 14.20 Mn |
| Sep 30, 2019 | 17.80 Mn |
| Jun 30, 2019 | 16.38 Mn |
| Mar 31, 2019 | 15.11 Mn |
| Dec 31, 2018 | 12.14 Mn |
| Sep 30, 2018 | 15.11 Mn |
| Jun 30, 2018 | 10.05 Mn |
| Mar 31, 2018 | 14.01 Mn |
| Dec 31, 2017 | 9.96 Mn |
| Jun 30, 2013 | 678,586.00 |
| Mar 31, 2013 | 691,033.00 |
| Dec 31, 2012 | 833,795.00 |
| Sep 30, 2012 | 1.12 Mn |
| Jun 30, 2012 | 1.21 Mn |
| Mar 31, 2012 | 970,388.00 |
| Dec 31, 2011 | 1.09 Mn |